News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,315 Results
Type
Article (16392)
Company Profile (50)
Press Release (267873)
Section
Business (83743)
Career Advice (1261)
Deals (15571)
Drug Delivery (23)
Drug Development (37352)
Employer Resources (93)
FDA (6410)
Job Trends (6409)
News (142956)
Policy (12231)
Tag
Academia (1386)
Alliances (21377)
Alzheimer's disease (722)
Approvals (6421)
Artificial intelligence (137)
Bankruptcy (120)
Best Places to Work (5703)
Breast cancer (151)
Cancer (1016)
Cardiovascular disease (62)
Career advice (1054)
Cell therapy (156)
Clinical research (30407)
Collaboration (349)
Compensation (62)
COVID-19 (1211)
C-suite (72)
Data (1039)
Diabetes (100)
Diagnostics (3807)
Earnings (39407)
Employer resources (85)
Events (37934)
Executive appointments (272)
FDA (6906)
Funding (267)
Gene therapy (96)
GLP-1 (231)
Government (1778)
Healthcare (8278)
Infectious disease (1271)
Inflammatory bowel disease (78)
Interviews (221)
IPO (8290)
Job creations (977)
Job search strategy (889)
Layoffs (93)
Legal (1946)
Lung cancer (132)
Manufacturing (93)
Medical device (5366)
Medtech (5368)
Mergers & acquisitions (7582)
Metabolic disorders (229)
Neuroscience (932)
NextGen: Class of 2025 (2537)
Non-profit (1673)
Northern California (1113)
Obesity (115)
Opinion (108)
Parkinson's disease (61)
Patents (88)
People (19794)
Phase I (9528)
Phase II (13517)
Phase III (10232)
Pipeline (463)
Postmarket research (1000)
Preclinical (3821)
Radiopharmaceuticals (138)
Rare diseases (142)
Real estate (1549)
Regulatory (9294)
Research institute (1289)
Resumes & cover letters (190)
Southern California (920)
Startups (1334)
United States (9507)
Vaccines (191)
Date
Today (75)
Last 7 days (349)
Last 30 days (1408)
Last 365 days (18540)
2025 (2282)
2024 (18850)
2023 (21576)
2022 (27159)
2021 (31011)
2020 (28371)
2019 (20736)
2018 (15287)
2017 (14556)
2016 (12757)
2015 (15237)
2014 (10455)
2013 (7753)
2012 (8183)
2011 (8530)
2010 (7584)
Location
Africa (361)
Asia (16265)
Australia (2734)
California (2441)
Canada (1051)
China (153)
Colorado (140)
Connecticut (145)
Europe (37362)
Florida (355)
Georgia (93)
Idaho (63)
Illinois (216)
Indiana (116)
Japan (66)
Maryland (337)
Massachusetts (1827)
Michigan (120)
Minnesota (167)
New Jersey (745)
New York (780)
North Carolina (387)
Northern California (1113)
Ohio (66)
Pennsylvania (553)
South America (491)
Southern California (920)
Texas (410)
Utah (69)
Virginia (64)
Washington State (254)
284,315 Results for "prisym id".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
February 5, 2025
·
2 min read
Press Releases
RID Launches a One-Button Solution for Microbiology Testing That Provides Pathogen ID and Antibiotic Sensitivity in 5 Hours
January 16, 2025
·
2 min read
Press Releases
FDA Grants IDE Approval for the Pivotal Trial of the JuxtaFlow® Renal Assist Device (RAD)
December 19, 2024
·
4 min read
Press Releases
ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
December 3, 2024
·
6 min read
Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study
Kardium Inc. announced today the successful completion of enrollment in the paroxysmal cohort of the pivotal PULSAR IDE (Investigational Device Exemption) study.
April 2, 2024
·
3 min read
Press Releases
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States
January 16, 2025
·
4 min read
Genetown
AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study
Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin its pivotal trial for pulsatile intravascular lithotripsy (PIVL) therapy.
June 6, 2024
·
2 min read
Press Releases
Inquis Medical Completes Enrollment in U.S. Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients with Pulmonary Embolism
January 13, 2025
·
3 min read
Press Releases
Theradaptive Obtains FDA IDE Approval to Study OsteoAdapt™ SP in Additional Spinal Fusion Indications
December 10, 2024
·
3 min read
Press Releases
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
February 3, 2025
·
4 min read
1 of 28,432
Next
